- Home
- PRLB vs NEO Comparison
PRLB vs NEO Comparison
Compare PRLB & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRLB | NEO |
|---|---|---|
| Founded | 1999 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Precision Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 2011 | 2008 |
Fundamental Metrics
Financial Performance| Metric | PRLB | NEO |
|---|---|---|
| Price | $88.65 | $16.81 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 12 |
| Target Price | ★ $95.50 | $21.85 |
| AVG Volume (30 Days) | 212.3K | ★ 2.4M |
| Earning Date | 10-29-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.33 | N/A |
| EPS | ★ 0.71 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.25 | $10.71 |
| Revenue Next Year | $7.56 | $9.96 |
| P/E Ratio | $129.32 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $45.10 | $7.07 |
| 52 Week High | $99.96 | $20.15 |
Technical Indicators
Market Signals| Indicator | PRLB | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 45.96 | 45.01 |
| Support Level | $77.11 | $15.72 |
| Resistance Level | $93.00 | $16.92 |
| Average True Range (ATR) | 3.24 | 0.96 |
| MACD | -0.98 | -0.28 |
| Stochastic Oscillator | 4.52 | 30.59 |
Price Performance
Historical ComparisonAbout PRLB Proto Labs Inc.
Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. The Lab uses injection molding, computer numerical control machining, and 3-D printing, and sheet metal to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. Geographically, a majority of the company's revenue is derived from the United States and the rest from Europe.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.